loadpatents
Patent applications and USPTO patent grants for Stem Cell & Regenerative Medicine International, Inc..The latest application filed is for "method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts".
Patent | Date |
---|---|
Method Of Generating Natural Killer Cells And Dendritic Cells From Human Embryonic Stem Cell-derived Hemangioblasts App 20150140657 - Kimbrel; Erin ;   et al. | 2015-05-21 |
Method of generating natural killer cells and dendritic cells from human embryonic stem cell-derived hemangioblasts Grant 8,822,218 - Kimbrel , et al. September 2, 2 | 2014-09-02 |
Large Scale Generation Of Functional Megakaryocytes And Platelets From Human Embryonic Stem Cells Under Stromal-free Conditions App 20120315338 - Li; Feng ;   et al. | 2012-12-13 |
Method Of Generating Natural Killer Cells And Dendritic Cells From Human Embryonic Stem Cell-derived Hemangioblasts App 20120282693 - Kimbrel; Erin ;   et al. | 2012-11-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.